| Tüüp : |
Ajaleht |
| Interneti link : |
https://doi.org/10.1155/2022/1931118 |
|
| Uurimisrühmad : |
Paris - Clinical Pharmacy Department, University Hospital Necker-Enfants Malades |
| Autor : |
Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J. |
| Pealkiri : |
Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. |
| Publikatsioon : |
The Scientific World Journal 2022 |
|
| Tõendite tase : |
|
| Füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
Ingredientide nimekiri
 Ruxolitinib
|
 |
 |
 |
 |
100 mg
Jakavi® (Novartis) |
|
2-8°C |
 |
| 60 |
 |
|
|
|
|
|
100 mg
Jakavi® (Novartis) |
|
22-25°C |
|
| 60 |
|
|
|
|
|
